Nige, should we listen to you instead? The person that said Afterpay was a dud investment and was sure to fail when it was around $8 just a few months ago? It's up 700% since, at over $60 a share now by the way.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%